Search

Your search keyword '"Montserrat Andreu"' showing total 261 results

Search Constraints

Start Over You searched for: Author "Montserrat Andreu" Remove constraint Author: "Montserrat Andreu"
261 results on '"Montserrat Andreu"'

Search Results

1. Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis

2. Narrow-band imaging and high-definition white-light endoscopy in patients with serrated lesions not fulfilling criteria for serrated polyposis syndrome: a randomized controlled trial with tandem colonoscopy

Catalog

Books, media, physical & digital resources

3. Accumulation of Paneth Cells in Early Colorectal Adenomas Is Associated with Beta-Catenin Signaling and Poor Patient Prognosis

4. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.

5. Accuracy of Colon Capsule Endoscopy in Detecting Colorectal Polyps in Individuals with Familial Colorectal Cancer: Could We Avoid Colonoscopies?

6. Genetic Variants Associated with Colorectal Adenoma Susceptibility.

7. Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program.

8. Colorectal cancer survival: Results from a hospital-based cancer registry Supervivencia del cáncer colorrectal: resultados de un registro hospitalario

9. A Truncated Form of IKKα Is Responsible for Specific Nuclear IKK Activity in Colorectal Cancer

10. Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.

11. Multiple sporadic colorectal cancers display a unique methylation phenotype.

12. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.

13. The MLH1 c.1852_1853delinsGC (p.K618A) variant in colorectal cancer: genetic association study in 18,723 individuals.

14. Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids.

15. A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer.

16. Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer.

17. Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish cohort.

18. Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue.

19. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

20. Additional figures and tables from TFAP2E Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal Cancer

21. Data from TFAP2E Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal Cancer

22. Supp Figure 4 from TFAP2E Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal Cancer

23. Supp Figure 3 from TFAP2E Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal Cancer

24. Supplemental Figure 1 from TFAP2E Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal Cancer

25. Supp Figure 2 from TFAP2E Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal Cancer

26. [The role of ferments in food sustainability]

27. Narrow-band imaging and high-definition white-light endoscopy in patients with serrated lesions not fulfilling criteria for serrated polyposis syndrome: a randomized controlled trial with tandem colonoscopy

28. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

29. Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry

30. Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s disease

31. Cribado poblacional de cáncer colorrectal: cánceres de intervalo y relación con el resultado cuantitativo del test inmunológico de sangre oculta en heces

32. Predictors of Metachronous Risk Polyps After Index Colonoscopy

33. Accumulation of paneth cells in early colorectal adenomas is associated with beta-catenin signaling and poor patient prognosis

34. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study

35. Meat intake, cooking methods and doneness and risk of colorectal tumours in the Spanish multicase-control study (MCC-Spain)

36. Narrow band imaging and white light endoscopy in the characterization of a polypectomy scar: A single-blind observational study

37. Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program

38. TFAP2E Methylation and Expression Status Does Not Predict Response to 5FU-based Chemotherapy in Colorectal Cancer

39. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy

40. Exome-wide pharmacogenomic analysis of response to thiopurines in inflammatory bowel disease patients

41. Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies

42. Identification of Risk Loci for Crohn’s Disease Phenotypes Using a Genome-Wide Association Study

43. Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer

44. Accuracy of Colon Capsule Endoscopy in Detecting Colorectal Polyps in Individuals with Familial Colorectal Cancer: Could We Avoid Colonoscopies?

45. Relationship between drugs affecting the renin-angiotensin system and colorectal cancer: The MCC-Spain study

46. Candidate predisposing germline copy number variants in early onset colorectal cancer patients

47. Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer

48. Risk of colectomy in patients with ulcerative colitis under thiopurine treatment

49. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening

50. Treatment of Colorectal Cancer with Unresectable Metastasis with Chemotherapy Without Primary Tumour Resection: Analysis of Tumour-related Complications